#AHA24 Scientific Sessions: University of Michigan (@umichmedicine + @umichcvc) experts available for comment on late-breaking science

Hi there, We are one day away from the 2024 American Heart Association Scientific Sessions. Experts from the University of Michigan Health Frankel Cardiovascular Center have several presentations, posters and discussions that cover the latest findings and innovations in the world…

Hackensack Meridian Mountainside Medical Center Nurse Wins Research Award at ACC Quality Summit

Alyssa Stolarik, RN, BSN, clinical coordinator of Cardiology at Hackensack Meridian Health Mountainside Medical Center, received the Second Best Research Poster Award at the American College of Cardiology (ACC) Quality Summit held in San Antonio, Texas. Her work, titled “Improving Compliance with Post-PCI Creatinine,” highlights significant advancements in the management of post-procedural care and patient outcomes. The research addresses the critical issue of acute kidney injury (AKI) post-percutaneous coronary intervention (PCI), demonstrating a marked reduction in risk-standardized AKI rates, which significantly surpasses national benchmarks.

Out of Africa: UT Southwestern cardiologist gets to the heart of Zambia’s No. 1 health threat

On a Thursday morning in Dallas, Fiona Strasserking, M.D., chats with her UT Southwestern colleague while internal medicine residents from the University of Zambia log on to their Zoom call. Rafic Berbarie, M.D., Associate Professor in UTSW’s Division of Cardiology, is today’s guest lecturer and the topic is “Evaluation of Chest Pain.”

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

First-of-its kind work led by Mount Sinai researcher supports reserving this technique for extreme cases

Unlocking Better Outcomes for Adults with Congenital Heart Disease

A recent publication in JAMA Network Open helps to shed light on the quality of life and health outcomes among adults with congenital heart disease (CHD) through critical findings from the Congenital Heart Initiative (CHI) registry. Ochsner Health pediatric cardiologist and adult congenital heart specialist, Thomas Young, MD, is a contributing author for the publication.

AI tool helps identify heart failure risk in diabetes patients

Researchers at UT Southwestern Medical Center have developed a machine learning model that can identify patients with diabetic cardiomyopathy, a heart condition characterized by abnormal changes in the heart’s structure and function that predisposes them to increased risk of heart failure. The findings, published in the European Journal of Heart Failure, offer a data-driven method to detect a high-risk diabetic cardiomyopathy phenotype, enabling early interventions that could help prevent heart failure in this vulnerable population.

Inaugural summit to explore artificial intelligence

A new virtual conference will explore how artificial intelligence (AI) can help health care providers and scientists efficiently analyze vast amounts of data and make more informed decisions, the Endocrine Society announced today.

Hackensack Meridian Mountainside Medical Center Cardiac Catheterization Laboratory Adopts Cathworks Technology

Hackensack Meridian Mountainside Medical Center’s Cardiac Catheterization Laboratory is proud to announce the integration of the Cathworks FFRangio® System, a cutting-edge non-invasive tool that enhances decision-making during coronary interventions. This advanced technology reaffirms the lab’s commitment to providing world-class care to patients with coronary artery disease.

Risk of clots, stroke from incorrect blood thinner dosing reduced using online dashboard

Doctors and pharmacists treating people with blood thinners can reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system, a study suggests. Direct oral anticoagulants can be incorrectly prescribed up to 20% of the time.

Expansión con luz del implante cardíaco de un niño

Los niños que nacen con ciertos defectos cardíacos se someten a un implante de shunt para mejorar el flujo sanguíneo. El shunt debe cambiarse a medida que el cuerpo crece. Los investigadores informan que un nuevo shunt expandible que reacciona a la luz podría reducir el número de cirugías a las que se someten estos niños. Presentarán sus resultados en la ACS Fall 2024.

Expanding a child’s heart implant with light

Children born with certain heart defects receive a shunt implant to improve blood flow. The shunt must be replaced as their bodies grow. Researchers say a new light-reactive expandable shunt could cut the number of surgeries these children receive. They will present their results at ACS Fall 2024.

Hackensack Meridian Jersey Shore University Medical Center Providing Patients the First Revisional, In-Stent Heart Treatment

Heart care experts at Hackensack Meridian Jersey Shore University Medical Center are now providing patients with the AGENTTM Drug-Coated Balloon (DCB), designed to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.

The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report®; Department of Geriatrics Claims No. 1 Spot in Specialty Rankings

The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence by U.S. News & World Report®, marking the ninth straight year the hospital has been listed among the top 20 in the country on the publication’s “Honor Roll.”

UT Southwestern once again ranked best hospital in DFW

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.

Cleveland Clinic Study Shows Weight Loss Surgery Cuts Risk of Heart Complications and Death in Patients with Obstructive Sleep Apnea and Obesity

A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated with a significantly lower risk of death and major adverse cardiovascular events, compared with patients who did not have the surgery. This study was published in the Journal of the American College of Cardiology.

Ali Aminian, M.D., director of Cleveland Clinic’s Bariatric & Metabolic Institute and primary investigator of the MOSAIC study, said, “The research shows that weight loss achieved with bariatric surgery is significantly associated with a 42% lower risk of major adverse cardiovascular events and 37% lower risk of death in patients with obesity and moderate to severe obstructive sleep apnea.”

Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

New York Valves 2024 Late-Breaking Clinical Trials and Science Announced

The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Providing Novel Irregular Heart Rhythm Treatment

Hackensack Meridian Hackensack University Medical Center and Hackensack Meridian Jersey Shore University Medical Center cardiologists have treated their first patients this week with the Medtronic PulseSelect Pulsed Field Ablation (PFA) System.

TCT 2024 Master Operator Award to Be Presented to Jeffrey W. Moses, MD

The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Jeffrey W. Moses, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30, 2024, in Washington, DC, at the Walter E. Washington Convention Center.

This Injectable Hydrogel Mitigates Damage to the Right Ventricle of the Heart

An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journals of the American College of Cardiology: Basic to Translational Science.  The study, by a research team from the University of California San Diego, Georgia Institute of Technology and Emory University, was conducted in rodents.

Traditional Chinese medicine reduces risk after heart attack

A traditional Chinese medicine whose name means “to open the network of the heart” reduced the risk of heart attacks, deaths, and other major cardiovascular complications for at least a year after a first heart attack, a study led by UT Southwestern Medical Center researchers shows. The findings, published in JAMA, reveal the promise of this compound, one of the first traditional Chinese medicines tested in a large-scale, Western-style clinical trial.

CRF Announces the 2023 Pulse-Setter Award Winners

The Cardiovascular Research Foundation (CRF) is proud to announce the winners of the 2023 Pulse-Setter Awards. The awardees will be honored at The Annual Pulse of the City Gala, CRF’s signature fundraising event, on December 8, 2023, at The Plaza in New York City. The Pulse-Setter Awards shine a spotlight on extraordinary individuals and initiatives whose dedication to innovation is driving positive change in medicine and health care.